GlaxoSmithKline: Restless Legs Syndrome trials

The registry lists 16 Restless Legs Syndrome studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 3Phase 2 2Phase 3 7Phase 4 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• REQUIP RLS Post Marketing SurveillanceCompletedNCT01327339Results posted
• Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)CompletedNCT01138124Results posted
• Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)TerminatedNCT00996944Phase 2Results posted
• Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs SyndromeCompletedNCT00530790Phase 2Results posted
• The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs SyndromeCompletedNCT00357097Phase 3Results posted
• Long-term Study Of Ropinirole In Restless Legs SyndromeCompletedNCT00329602Phase 4Results posted
• Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)CompletedNCT00256854Phase 3Results posted
• A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of RopiniroleCompletedNCT00422994Phase 1
• Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of FoodCompletedNCT00419692Phase 1
• 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs SyndromeCompletedNCT00373542Phase 4
• A Clinical Research Study Testing Ropinirole Treatment for Restless Legs SyndromeCompletedNCT00363857Phase 3
• Long-Term Safety Of Ropinirole XR In Patients With Restless Legs SyndromeCompletedNCT00355641Phase 3
• RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of RopiniroleCompletedNCT00314860Phase 3
• A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)CompletedNCT00225862Phase 3
• Ropinirole XR (Extended Release) In Patients With Restless Legs SyndromeCompletedNCT00197080Phase 3
• Ropinirole Tablets In Young Patients With Restless Legs SyndromeCompletedNCT00140712Phase 1